En ” matched- pair ” overlevelsesanalyse af patienter behandlet med Beromun og melfalan ILP sammenlignet med en historisk kontrol kunne ikke vise en overlevelsesdifference (p=0, 5).
A matched-pair survival analysis of patients treated by Beromun and melphalan ILP as compared to a historical control failed to demonstrate any survival difference (p=0.5).